TY  - GEN
AU  - Jain,Rajul K
AU  - Hong,David S
AU  - Naing,Aung
AU  - Wheler,Jennifer
AU  - Helgason,Thorunn
AU  - Shi,Nai-Yi
AU  - Gad,Yash
AU  - Kurzrock,Razelle
TI  - Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies
SN  - 1551-4005
PY  - 2016///0829
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bortezomib
KW  - administration & dosage
KW  - Computer Simulation
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - G1 Phase Cell Cycle Checkpoints
KW  - drug effects
KW  - G2 Phase Cell Cycle Checkpoints
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Models, Biological
KW  - Molecular Targeted Therapy
KW  - Neoplasms
KW  - drug therapy
KW  - S Phase Cell Cycle Checkpoints
KW  - Sirolimus
KW  - Texas
KW  - Time Factors
KW  - Topotecan
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1080/15384101.2015.1090065
ER  -